extra small siz normal size extra large size
print
email

Edit email address
Invalid email
Email Sent
Authorize the processing of personal data

Pipeline

A BALANCED AND TARGETED PIPELINE

 

The number of ongoing research programs continues to increase year after year. Chiesi USA is predominantly focused on the key areas of respiratory, neonatology, and special care.

 

RESPIRATORY

The respiratory area is the hub of Research & Development activities. These R&D activities are constantly expanding to address areas of therapeutic need in asthma, chronic obstructive pulmonary disease, and other respiratory diseases.

Chiesi USA’s development pipeline consists of new molecular entities and continues to make significant progress. Programs include innovative anti-inflammatory, bronchodilator, and antifibrotic molecules.

pipeline_resp_1

 

NEONATOLOGY

Research and Development programs in this therapeutic area are focused devastating respiratory diseases and conditions of the newborn. New programs have progressed and have been added as candidates for the treatment of these other neonatal conditions.

pipeline_neo_1

SPECIAL CARE

Research and Development in the area of Special Care is focused on cardiovascular conditions. The anti-thrombotic candidate CUSA 081 is now in an advanced stage of development.

pipeline_rare_1